APPLICATION
ANDA202476
TYPE
ANDA
ORIGINAL APPROVAL
2013-05-14
LATEST ACTION
2013-05-14
ROUTE
ORAL
DOSAGE FORM
TABLET, ORALLY DISINTEGRATING
MARKETING STATUS
Discontinued
Products
ZOLMITRIPTANDiscontinued
ZOLMITRIPTAN 2.5MG · TABLET, ORALLY DISINTEGRATING · ORAL
ZOLMITRIPTANDiscontinued
ZOLMITRIPTAN 5MG · TABLET, ORALLY DISINTEGRATING · ORAL
Approval history
2013-05-14UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.